MedTrace Logo

Management and Healthcare Utilization of Patients With Chronic Airway Disease During the COVID-19 Epidemic

NCT04948216 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 153

Last updated 2021-07-06

No results posted yet for this study

Summary

During the COVID-19 epidemic, the medical treatment, disease status, and medication status of patients with chronic airway disease have not been studied. The purpose of this study is to investigate the management and healthcare utilization of patients with chronic airway disease and the influencing factors during the COVID-19 epidemic.

Conditions

  • Pulmonary Disease, Chronic Obstructive
  • Asthma

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Principal Investigators

  • Yongchang Sun, M.D. · Peking University Third Hospital

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-28
Primary Completion
2020-05-13
Completion
2020-05-13

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04948216 on ClinicalTrials.gov